Welcome to the BRAIN TUMORS 2016 - FROM BIOLOGY TO THERAPY Conference

  • Collage
  • Collage breaks
  • Collage Deenen
  • Collage Kotulska
  • Collage Kryut
  • Collage Kaminska

Dear Colleagues,

It is my big pleasure and honor to invite You to participate in the "Brain Tumors Meeting 2016 - From Biology to Therapy", which will take place on June 27-29, 2016 in Warsaw, Poland. The conference is organized by the Nencki Institute of Experimental Biology, Institute of Psychiatry and Neurology, and Foundation of Clinical and Experimental Oncology. The conference will take place at the conference hall of the Neurobiology Center, Nencki Institute of Experimental Biology, 3 Pasteur str., Warsaw.

The main advantage of the conference is its high scientific quality, avoidance of parallel scientific sessions, enough planned time for discussion, specialized topics focused on basic and clinical research on brain tumor biology and therapy. During the Meeting the lectures will be presented by internationally recognized experts and will cover recent advances in pathobiology, immunology, diagnosis and therapy of brain tumors. Complex interactions between tumor cells, microenvironment and host immunity will be discussed. The conference provides unique opportunity for students and young investigators to present posters and be selected for short talks. Collegial environment will foster interdisciplinary cross-talks and spark new scientific collaborations.

See You in Warsaw

Prof. Bozena Kaminska


Chair of the Organizing Committee


MONDAY, 27 June 2016
08.00-09.00 Registration
09.00-09.10 Opening remarks
Origin of brain tumors and glioblastoma heterogeneity Chairs: Dolores Hambardzumyan, Bozena Kaminska

Keynote lecture: Colin Watts (University of Cambridge, UK) - Surgical strategies to interrogate the genomics of glioblastoma.


Dominik Sturm (University Hospital Heidelberg and German Cancer Research Center, Germany) - Molecular characterization of CNS primitive neuroektodermal tumors

10.40-11.10 Coffee break
11.10-11.50 Lene Uhrbom (University of Uppsala, Sweden) - A cell of origin–based strategy to decipher glioblastoma biology
11.50-12.30 Simone Niclou (Luxemburg Institute of Health, Luxemburg) - Resolving genetic and phenotypic heterogeneity in glioblastoma
12.30-13.10 Ben Deneen (Baylor College of Medicine, Houston, USA) - Identification of diverse astrocytic populations and their emergence during glioma induced seizures
13.10-14.00 Lunch break and sponsored lectures
Brain tumor therapy I Chairs: Zvi Cohen, Pawel Nauman
14.00-14.40 Zvi Cohen (Sheba Medical Center, Tel Ashomer, Israel) - Harnessing nanomedicine as a new approach for GBM treatment
14.40-15.20 Geoffrey Pilkington (University of Portsmouth, UK) - Re-purposed drugs for brain tumour
15.20-16.00 Joan Seoane (Valld’Hebron Institute of Oncology, Spain) - Glioblastoma microenvironment
16.00-16.30 Coffee break 
16.30 17.10

Oral Presentations:

Susan Brandenburg (Charité - Universitätsmedizin Berlin, Germany) - In human GBM, the pro-angiogenic phenotype of microglia/macrophages depends on the infiltration rate of granulocytes

Roland E. Kälin (University Clinics, LMU Munich, Germany) - Apelin signaling controls glioblastoma neo-vascularization and growth

Dominika Pszczolkowska (Nencki Institute of Experimental Biology, Poland) - Tumor-derived osteopontin via its RGD motif is responsible for the protumorigenic reprogramming of glioma- infiltrating microglia/macrophages and glioma growth

17.10-17.50 Rolf Bjerkvig (University of Bergen, Norway) - Identifying new drugs for primary and secondary brain tumours using cMap
18.30-21.00 Welcome reception
TUESDAY, 28 June 2016
Signaling in brain tumors Chairs: Lene Uhrbom, Aleksandra Ellert-Miklaszewska

Keynote lecture: Daniel J. Brat (Winship Cancer Institute of Emory University, Atlanta, USA) - A contemporary molecular view of diffuse gliomas with implications for diagnosis


Ksenya Shchors (Swiss Federal Institute of Technology, Switzerland) - Combinatorial therapy design in glioblastoma models

10.30-11.00 Coffee break

Etty (Tika) Benveniste (University of Alabama, Birmingham, USA) - Role of CK2 in GBM and autoimmunity

11.40-12.20 Bozena Kaminska (Nencki Institute, Warsaw, Poland) - Glioma-derived osteopontin/SPP1 supports glioma stem-like cells and shapes anti-tumor responses
12.20-13.10 Lunch break
Glioma immunology and immunotherapy Chairs: Tika Benveniste, Katarzyna Kotulska

Duane Mitchell  (University of Florida, USA) - Cellular immunotherapy targeting malignant gliomas

13.50-14.30 Dolores Hambardzumyan (Emory University School of Medicine, Atlanta, USA) - The role of pro-inflammatory chemokine network in gliomagenesis
14.30-15.10 Christel Herold-Mende (University Hospital Heidelberg, Germany) - Immunological changes during tumor progression from primary to recurrent glioblastoma
15.10-15.40 Coffee break
15.40-16.20 Michael Platten (University Hospital Heidelberg and German Cancer Research Center, Germany) - Targeting IDH1R132H for glioma immunotherapy
16.20-17.00 Gaetano Finocchiaro (IRCCS Foundation "C. Besta" Neurological Institute, Milan, Italy) - Glioblastoma immunotherapy
17.00-19.00 Poster session (wine and cheese by the posters)
20.00-22.00 Gala Dinner (by invitation)
WEDNESDAY, 29 June 2016
Glioma signaling and biology Chairs: Frank AE Kruyt, Cristina Limatola

Keynote lecture: Katarzyna Kotulska (The Children’s Memorial Health Institute, Poland) - mTOR inhibitors in tuberous sclerosis: from brain tumor treatment to the control of systemic disease

09.40-10.20 Monika Hegi (University Hospital Lausanne, Switzerland) - Epigenetic Deregulation in Glioma, Biomarkers and New Opportunities
10.20-11.00 François Vallette (University of Nantes, France) - Identification of a drug tolerant stage during the acquisition of TMZ resistance in glioma
11.00-11.30 Coffee break

Steven Rosenfeld (Cleveland Clinic, USA) - Molecular motors are drivers of proliferation and invasion in glioblastoma

12.10-12.50 Frank AE Kruyt (University of Groningen, Netherlands) - Differentiation and invasion in glioblastoma
12.50-13.30 Cristina Limatola (Sapienza University, Rome, Italy) - Environmental and pharmacological tools to reprogram microglia/macrophages infiltrating brain tumor
13.30-14.10 Jacek Jaworski (International Institute of Molecular and Cellular Biology, Warsaw, Poland) - Tuberous Sclerosis Complex neuropathology requires glutamate-cysteine ligase
14.10-14.40 Farewell lunch
14.40... Guided tour: Warsaw sightseeing

Scientific Committee

  • Etty (Tika) Benveniste, University of Alabama, USA
  • Karin Forsberg- Nilsson, Uppsala University, Sweden
  • Dolores Hambardzumyan, Emory University, USA
  • Bozena Kaminska, Nencki Institute, Poland

The Local Organizing Committee

  • Aleksandra Ellert-Miklaszewska, Nencki Institute
  • Anna Gieryng, Nencki Institute
  • Bozena Kaminska, Nencki Institute
  • Marta Maleszewska, Nencki Institute
  • Pawel Nauman, Institute of Psychiatry and Neurology
  • Cezary Szczylik, Central Military Hospital
  • Pawel Wisniewski, Helix Polska

Registration Deadlines and Pricing

You may register for this meeting on this web site until May 30, 2016.

The Registration Fee includes: admission to speaker talks and poster displays, abstract book, coffee breaks service, refreshments at poster sessions, Welcome Reception

Academic Fees

The Registration Fee is €200 on and before April 30, 2016.
After April 30, 2016 or onsite, the Registration Fee is €260.

Student Fees

All students are offered a special registration rate.
To qualify for the Student Discount, you must be enrolled in an undergraduate, M.S., Ph.D. or M.D. program.

The Student Registration Fee is €50.

Corporate Fees

The Registration Fee is €300 on and before April 30, 2016.
After April 30, 2016 or onsite, the Registration Fee is €400.


By bank transfer to the following account:

ACCOUNT NO IBAN: PL95 1130 1017 0013 4337 2320 0008

Please do not forget to indicate "Brain Tumors 2016" and your name and affiliation on the money transfer form.


More About Warsaw

logo WCB WOT

warsawtour5 warsawtour1